Analystreport

Collegium Pharmaceutical Inc (NASDAQ: COLL) had its price target raised by analysts at SunTrust Banks, Inc. to $22.00. They now have a "buy" rating on the stock.

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com